# Preemptive Oral Lactium to Prevent Emergence Agitation

> **NCT07172594** · NA · COMPLETED · sponsor: **Tanta University** · enrollment: 135 (actual)

## Conditions studied

- Lactium
- Emergence Agitation
- Adenotonsillectomy

## Interventions

- **DRUG:** Lactium
- **OTHER:** Placebo control

## Key facts

- **NCT ID:** NCT07172594
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-09-22
- **Primary completion:** 2026-01-08
- **Final completion:** 2026-01-08
- **Target enrollment:** 135 (ACTUAL)
- **Last updated:** 2026-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07172594

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07172594, "Preemptive Oral Lactium to Prevent Emergence Agitation". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT07172594. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*